The potential role of associating liver partition and portal vein ligation in the treatment of colorectal liver metastases  

作　　者：Jan P.Jonas Henrik Petrowsky 

机构地区：[1]Swiss HPB and Transplantation Center,Department of Surgery,University Hospital Zurich,Zurich,Switzerland [2]HPB Center,Department of Surgery,Clinic Favoriten,Vienna,Austria

出　　处：《Hepatobiliary Surgery and Nutrition》2021年第6期902-905,共4页肝胆外科与营养（英文）

摘　　要：Life expectancy of patients with colorectal liver metastasis(CRLM)significantly improved over the last decades due to the induction of multimodal effective treatment strategies including perioperative chemotherapy and advanced surgical procedures.By conversion chemotherapy,previously unresectable CRLMs can be converted to a resectable situation and amenable to procedures such as associating liver partition and portal vein ligation(ALPPS)(1).A recent publication in HBSN has extensively reviewed ALPPS as a concept in the treatment of CRLM.This review article by Glinka et al.(2)focuses on the evolvement of this novel procedure and describes in detail the gradual changes accompanying this procedure’s evolvement since 2007.Further,the authors highlight several aspects crucial for the best possible outcome after this procedure including patient selection,future liver remnant,technical aspects,safety,morbidity,mortality and oncological results.

关 键 词：CHEMOTHERAPY COLORECTAL TREATMENT 

分 类 号：R73[医药卫生—肿瘤]